GPT Pharmaceuticals Private Limited, the Financial Creditor (FC), filed an application under Section 7 of the Insolvency and Bankruptcy Code (IBC) to initiate the Corporate Insolvency Resolution Process (CIRP) against Punarnava Rasayan Private Limited, the Corporate Debtor (CD). The FC claimed to have provided financial assistance to the CD, evidenced by a Loan Agreement dated 30.05.2020, for Rs.4,79,63,303 at 18% interest per annum. The repayment was to be made in six installments. The FC alleged that the CD defaulted on 30.06.2021, leading to the application. The CD raised objections regarding the lack of proper authorization for filing the application and questioned the commencement of CIRP. They also claimed they did not receive the loan and alleged misuse of the
…GPT Pharmaceuticals Private Limited (FC) claimed to have extended a loan of Rs.4,79,63,303 to Punarnava Rasayan Private Limited (CD) as per a Loan Agreement dated 30.05.2020, with an 18% annual interest rate. The repayment was structured in six installments from 30.05.2021 to 30.01.2022. The FC alleged a default on 30.06.2021, leading to a Section 7 IBC application. The CD contested the application, citing a lack of proper authorization and denying receipt of the loan. The CD also alleged misuse of the IBC by the FC. The Loan Agreement, central to the FC's claim, showed discrepancies in repayment terms and lacked disbursement details. The stamp paper used for the agreement was purchased three years prior to the agreement date. The loan was not reflected in the FC's
…Sign in to view the parties.
Stamp paper for the…
The Loan Agreement records that as on…
GPT Pharmaceuticals Private Limited, the Financial Creditor (FC), filed an application under Section 7 of the Insolvency and Bankruptcy Code (IBC) to initiate the Corporate Insolvency Resolution Process (CIRP) against Punarnava Rasayan Private Limited, the Corporate Debtor (CD). The FC claimed to have provided financial assistance to the CD, evidenced by a Loan Agreement dated 30.05.2020, for Rs.4,79,63,303 at 18% interest per annum. The repayment was to be made in six installments. The FC alleged that the CD defaulted on 30.06.2021, leading to the application. The CD raised objections regarding the lack of proper authorization for filing the application and questioned the commencement of CIRP. They also claimed they did not receive the loan and alleged misuse of the
…GPT Pharmaceuticals Private Limited (FC) claimed to have extended a loan of Rs.4,79,63,303 to Punarnava Rasayan Private Limited (CD) as per a Loan Agreement dated 30.05.2020, with an 18% annual interest rate. The repayment was structured in six installments from 30.05.2021 to 30.01.2022. The FC alleged a default on 30.06.2021, leading to a Section 7 IBC application. The CD contested the application, citing a lack of proper authorization and denying receipt of the loan. The CD also alleged misuse of the IBC by the FC. The Loan Agreement, central to the FC's claim, showed discrepancies in repayment terms and lacked disbursement details. The stamp paper used for the agreement was purchased three years prior to the agreement date. The loan was not reflected in the FC's
…Stamp paper for the…
The Loan Agreement records that as on…